Deokbae Park, 2022: Park reports that in H4IIE hepatoma cells fenbendazole does not change glucose consumption, lactate production or ROS, and attributes the effect to p21-mediated cell-cycle arrest instead.
Glycolytic changes (glucose consumption and lactate production) and the generation of reactive oxygen species (ROS) were not affected by FZ.
Deokbae Park, 2022: Park reports that in H4IIE hepatoma cells fenbendazole does not change glucose consumption, lactate production or ROS, and attributes the effect to p21-mediated cell-cycle arrest instead. Study type: H4IIE rat hepatoma cell line, two growth conditions. N: not applicable. Country: Korea (Jeju National University). Dose: not stated in the abstract text captured. Funder: not stated in the record. Declared conflicts: no COI statement in the record. Comparator: quiescent versus actively growing cells. This is the clearest contrary document for C3: the same laboratory that reported 5-FU-resistant colorectal killing reports no glycolytic effect in this model, so the glycolysis mechanism is cell-type dependent, not general. Also filed as FBC-12, FBC-23 (claims C2, C3, C4). Study type: lab.
